ST-Segment-Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors-How Common Are They, and What Are Their Outcomes?
Age Factors
Aged
Angiotensin Receptor Antagonists
/ therapeutic use
Australia
/ epidemiology
Creatinine
/ blood
Female
Heart Arrest
/ epidemiology
Heart Failure
/ epidemiology
Heart Rate
Hospital Mortality
Hospitalization
Humans
Hypertension
/ epidemiology
Male
Middle Aged
Multivariate Analysis
Patient Transfer
/ statistics & numerical data
Percutaneous Coronary Intervention
/ statistics & numerical data
Registries
ST Elevation Myocardial Infarction
/ epidemiology
Systole
Thrombolytic Therapy
/ statistics & numerical data
ST‐segment–elevation myocardial infarction
atherosclerosis
mortality
risk factor
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
05 11 2019
05 11 2019
Historique:
entrez:
2
11
2019
pubmed:
2
11
2019
medline:
15
12
2020
Statut:
ppublish
Résumé
Background Programs targeting the standard modifiable cardiovascular risk factors (SMuRFs: hypertension, diabetes mellitus, hypercholesterolemia, smoking) are critical to tackling coronary heart disease at a community level. However, myocardial infarction in SMuRF-less individuals is not uncommon. This study uses 2 sequential large, multicenter registries to examine the proportion and outcomes of SMuRF-less ST-segment-elevation myocardial infarction (STEMI) patients. Methods and Results We identified 3081 STEMI patients without a prior history of cardiovascular disease in the Australian GRACE (Global Registry of Acute Coronary Events) and CONCORDANCE (Cooperative National Registry of Acute Coronary Syndrome Care) registries, encompassing 42 hospitals, between 1999 and 2017. We examined the proportion that were SMuRF-less as well as outcomes. The primary outcome was in-hospital mortality, and the secondary outcome was major adverse cardiovascular events (death, myocardial infarction, or heart failure, during the index admission). Multivariate regression models were used to identify predictors of major adverse cardiovascular events. Of STEMI patients without a prior history of cardiovascular disease 19% also had no history of SMuRFs. This proportion increased from 14% to 23% during the study period (
Identifiants
pubmed: 31672080
doi: 10.1161/JAHA.119.013296
pmc: PMC6898813
doi:
Substances chimiques
Angiotensin Receptor Antagonists
0
Creatinine
AYI8EX34EU
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e013296Références
J Am Coll Cardiol. 2002 Jan 16;39(2):257-65
pubmed: 11788217
Eur Heart J. 2016 Aug 1;37(29):2315-2381
pubmed: 27222591
Am J Public Health Nations Health. 1957 Apr;47(4 Pt 2):4-24
pubmed: 13411327
J Am Heart Assoc. 2019 Nov 5;8(21):e013296
pubmed: 31672080
Arch Intern Med. 2006 Jul 10;166(13):1368-73
pubmed: 16832001
Eur Heart J. 2014 Sep 1;35(33):2232-41
pubmed: 24366919
Eur J Prev Cardiol. 2017 Nov;24(17):1824-1830
pubmed: 28703626
Heart Lung Circ. 2018 Dec;27(12):1398-1405
pubmed: 29066011
Lancet. 2016 Oct 8;388(10053):1459-1544
pubmed: 27733281
JAMA. 2011 Nov 16;306(19):2120-7
pubmed: 22089719
Ann Intern Med. 1961 Jul;55:33-50
pubmed: 13751193
Eur J Intern Med. 2013 Jun;24(4):295-302
pubmed: 23647842
Circulation. 1998 May 12;97(18):1837-47
pubmed: 9603539
Am Heart J. 2007 Apr;153(4):507-14
pubmed: 17383286
Vasc Health Risk Manag. 2007;3(5):629-37
pubmed: 18078014
J Am Coll Cardiol. 2017 Jul 4;70(1):1-25
pubmed: 28527533
Can J Cardiol. 2015 Dec;31(12):1455-61
pubmed: 26143140
Microcirculation. 2019 Feb;26(2):e12488
pubmed: 29956866
JAMA. 2003 Aug 20;290(7):898-904
pubmed: 12928466
Environ Res. 2017 Nov;159:16-23
pubmed: 28763730
J Am Coll Cardiol. 2015 Mar 17;65(10):963-72
pubmed: 25766941
Heart. 2010 Jul;96(14):1095-101
pubmed: 20511625
Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73
pubmed: 24222018
J Am Coll Cardiol. 2018 Jan 23;71(3):292-302
pubmed: 29141201
J Am Coll Cardiol. 2017 Dec 19;70(24):2979-2991
pubmed: 29241485
Am J Cardiol. 2002 Aug 15;90(4):358-63
pubmed: 12161222
Lancet. 2002 Dec 14;360(9349):1903-13
pubmed: 12493255
J Am Coll Cardiol. 2016 May 24;67(20):2411-2418
pubmed: 27199065
J Am Coll Cardiol. 2018 Oct 16;72(16):1883-1893
pubmed: 30309464
Eur Heart J. 2002 Aug;23(15):1190-201
pubmed: 12127921
JAMA. 2007 Feb 14;297(6):611-9
pubmed: 17299196